Diclac ID 150 tablets modified-release Armenia - English - Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում

diclac id 150 tablets modified-release

salutas pharma gmbh - diclofenac (diclofenac sodium) with immediate release, diclofenac (diclofenac sodium) with prolonged release - tablets modified-release - 25mg+ 125mg

Diclofenac 50 mg/Misoprostol 200 micrograms modified release tablets Ireland - English - HPRA (Health Products Regulatory Authority)

diclofenac 50 mg/misoprostol 200 micrograms modified release tablets

morningside healthcare ltd - diclofenac sodium; misoprostol - modified-release tablet - 50 mg/200 microgram(s) - acetic acid derivatives and related substances; diclofenac, combinations

DICLOFENAC SODIUM AND MISOPROSTOL DELAYED-RELEASE- diclofenac sodium and misoprostol tablet, delayed release United States - English - NLM (National Library of Medicine)

diclofenac sodium and misoprostol delayed-release- diclofenac sodium and misoprostol tablet, delayed release

blenheim pharmacal, inc. - diclofenac sodium (unii: qtg126297q) (diclofenac - unii:144o8ql0l1), misoprostol (unii: 0e43v0bb57) (misoprostol - unii:0e43v0bb57) - diclofenac sodium 75 mg - carefully consider the potential benefits and risks of diclofenac sodium and misoprostol delayed-release tablets and other treatment options before deciding to use diclofenac sodium and misoprostol delayed-release tablets. use the lowest effective dose for the shortest duration consistent with individual patient treatment goals (see warnings ). diclofenac sodium and misoprostol delayed-release tablets are indicated for treatment of the signs and symptoms of osteoarthritis or rheumatoid arthritis in patients at high risk of developing nsaid-induced gastric and duodenal ulcers and their complications. see warnings, gastrointestinal effects - risk of ulceration, bleeding and perforation for a list of factors that may increase the risk of nsaid-induced gastric and duodenal ulcers and their complications. see boxed contraindications and warnings related to misoprostol. diclofenac sodium and misoprostol delayed-release tablets should not be taken by pregnant women. diclofena

Diclo SR New Zealand - English - Medsafe (Medicines Safety Authority)

diclo sr

clinect nz pty limited - diclofenac sodium 100mg - modified release tablet - 100 mg - active: diclofenac sodium 100mg excipient: dextrates hyetellose hypromellose iron oxide red iron oxide yellow macrogol 3350 magnesium stearate microcrystalline cellulose titanium dioxide - diclofenac is used for the relief of moderate pain and inflammation in: - rheumatic disorders: e.g. ankylosing spondylitis, osteoarthritis, and rheumatoid arthritis including juvenile rheumatoid arthritis, painful syndromes of the vertebral column, nonarticular rheumatism. - painful post-operative inflammation and swelling (including dental and orthopaedic procedures). - painful or inflammatory gynaecological conditions e.g. primary dysmenorrhoea. - in keeping with general therapeutic principles, the underlying disease should be treated with basic therapy, as appropriate. diclofenac provides symptomatic relief but has not been shown to halt or reverse the underlying disease process. fever alone is not an indication.

Diclo SR New Zealand - English - Medsafe (Medicines Safety Authority)

diclo sr

clinect nz pty limited - diclofenac sodium 75mg - modified release tablet - 75 mg - active: diclofenac sodium 75mg excipient: carnauba wax dextrates hyetellose hypromellose iron oxide red macrogol 3350 magnesium stearate microcrystalline cellulose purified water titanium dioxide - diclofenac is used for the relief of moderate pain and inflammation in: - rheumatic disorders: e.g. ankylosing spondylitis, osteoarthritis, and rheumatoid arthritis including juvenile rheumatoid arthritis, painful syndromes of the vertebral column, nonarticular rheumatism. - painful post-operative inflammation and swelling (including dental and orthopaedic procedures). - painful or inflammatory gynaecological conditions e.g. primary dysmenorrhoea. - in keeping with general therapeutic principles, the underlying disease should be treated with basic therapy, as appropriate. diclofenac provides symptomatic relief but has not been shown to halt or reverse the underlying disease process. fever alone is not an indication.

DICLOFENAC SODIUM AND MISOPROSTOL DELAYED-RELEASE- diclofenac sodium and misoprostol tablet, delayed release United States - English - NLM (National Library of Medicine)

diclofenac sodium and misoprostol delayed-release- diclofenac sodium and misoprostol tablet, delayed release

eagle pharmaceuticals, inc. - diclofenac sodium (unii: qtg126297q) (diclofenac - unii:144o8ql0l1), misoprostol (unii: 0e43v0bb57) (misoprostol - unii:0e43v0bb57) - diclofenac sodium 50 mg - carefully consider the potential benefits and risks of diclofenac sodium and misoprostol delayed-release tablets and other treatment options before deciding to use diclofenac sodium and misoprostol delayed-release tablets. use the lowest effective dose for the shortest duration consistent with individual patient treatment goals (see warnings ). diclofenac sodium and misoprostol delayed-release tablets are indicated for treatment of the signs and symptoms of osteoarthritis or rheumatoid arthritis in patients at high risk of developing nsaid-induced gastric and duodenal ulcers and their complications. see warnings, gastrointestinal effects - risk of ulceration, bleeding and perforation for a list of factors that may increase the risk of nsaid-induced gastric and duodenal ulcers and their complications. see boxed contraindications and warnings related to misoprostol. diclofenac sodium and misoprostol delayed-release tablets should not be taken by pregnant women. diclofenac sodium and misoprostol delayed-releas

Diclac ID 75 tablets modified-release Armenia - English - Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում

diclac id 75 tablets modified-release

salutas pharma gmbh - diclofenac (diclofenac sodium) with immediate release, diclofenac (diclofenac sodium) with prolonged release - tablets modified-release - 12,5mg+ 62,5mg

Diclofenac 75 mg/Misoprostol 200 micrograms modified release tablets Ireland - English - HPRA (Health Products Regulatory Authority)

diclofenac 75 mg/misoprostol 200 micrograms modified release tablets

morningside healthcare ltd - diclofenac sodium; misoprostol - modified-release tablet - 75 mg/200 microgram(s) - antiinflammatory/antirheumatic agents in combination with corticosteroids; acetic acid derivatives and related substances

Fenadol 100mg modified-release Tablets Malta - English - Medicines Authority

fenadol 100mg modified-release tablets

proge farm s.r.l. baluardo la marmora, 4 - 28100 - novara, italy - diclofenac sodium - modified-release tablet - diclofenac sodium 100 mg - antiinflammatory and antirheumatic products